These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 10585754

  • 1. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.
    Ablamunits V, Quintana F, Reshef T, Elias D, Cohen IR.
    J Autoimmun; 1999 Dec; 13(4):383-92. PubMed ID: 10585754
    [Abstract] [Full Text] [Related]

  • 2. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY, Singh B.
    J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
    [Abstract] [Full Text] [Related]

  • 3. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.
    Herold KC, Vezys V, Sun Q, Viktora D, Seung E, Reiner S, Brown DR.
    J Immunol; 1996 May 01; 156(9):3521-7. PubMed ID: 8617981
    [Abstract] [Full Text] [Related]

  • 4. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.
    Moritani M, Yoshimoto K, Ii S, Kondo M, Iwahana H, Yamaoka T, Sano T, Nakano N, Kikutani H, Itakura M.
    J Clin Invest; 1996 Oct 15; 98(8):1851-9. PubMed ID: 8878437
    [Abstract] [Full Text] [Related]

  • 5. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
    Yasuda H, Jin Z, Nakayama M, Yamada K, Kishi M, Okumachi Y, Arai T, Moriyama H, Yokono K, Nagata M.
    Diabetes Res Clin Pract; 2009 Feb 15; 83(2):200-7. PubMed ID: 19117633
    [Abstract] [Full Text] [Related]

  • 6. G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse.
    Hadaya K, Kared H, Masson A, Chatenoud L, Zavala F.
    J Autoimmun; 2005 Mar 15; 24(2):125-34. PubMed ID: 15829405
    [Abstract] [Full Text] [Related]

  • 7. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S, Penna G, Gregori S, Chapman HD, Serreze DV, Magram J, Adorini L.
    J Immunol; 1999 Sep 01; 163(5):2960-8. PubMed ID: 10453045
    [Abstract] [Full Text] [Related]

  • 8. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
    Mori Y, Kato T, Kodaka T, Kanagawa EM, Hori S, Kanagawa O.
    Int Immunol; 2008 Sep 01; 20(9):1231-7. PubMed ID: 18644830
    [Abstract] [Full Text] [Related]

  • 9. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
    Ablamunits V, Elias D, Reshef T, Cohen IR.
    J Autoimmun; 1998 Feb 01; 11(1):73-81. PubMed ID: 9480725
    [Abstract] [Full Text] [Related]

  • 10. Prolactin regulation of the expression of TNF-alpha, IFN-gamma and IL-10 by splenocytes in murine multiple low dose streptozotocin diabetes.
    Lau J, Börjesson A, Holstad M, Sandler S.
    Immunol Lett; 2006 Jan 15; 102(1):25-30. PubMed ID: 16054232
    [Abstract] [Full Text] [Related]

  • 11. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
    Takahashi K, Satoh J, Sagara M, Zhu XP, Muto G, Muto Y, Fukuzawa M, Nishimura S, Miyaguchi S, Toyata T.
    J Autoimmun; 1995 Jun 15; 8(3):335-46. PubMed ID: 7575995
    [Abstract] [Full Text] [Related]

  • 12. Preventative effects of the flowers of Inula britannica on autoimmune diabetes in C57BL/KsJ mice induced by multiple low doses of streptozotocin.
    Kobayashi T, Song QH, Hong T, Kitamura H, Cyong JC.
    Phytother Res; 2002 Jun 15; 16(4):377-82. PubMed ID: 12112297
    [Abstract] [Full Text] [Related]

  • 13. Human LT-alpha-mediated resistance to autoimmune diabetes is induced in NOD, but not NOD-scid, mice and abrogated by IL-12.
    Miyaguchi S, Satoh J, Takahashi K, Sakata Y, Nakazawa T, Miyazaki J, Toyota T.
    Clin Immunol; 2001 Jan 15; 98(1):119-24. PubMed ID: 11141334
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
    Stosic-Grujicic S, Stojanovic I, Maksimovic-Ivanic D, Momcilovic M, Popadic D, Harhaji L, Miljkovic D, Metz C, Mangano K, Papaccio G, Al-Abed Y, Nicoletti F.
    J Cell Physiol; 2008 Jun 15; 215(3):665-75. PubMed ID: 18064633
    [Abstract] [Full Text] [Related]

  • 17. Impact of plastic adhesion in vitro on analysis of Th1 and Th2 cytokines and immune cell distribution from mice with multiple low-dose streptozotocin-induced diabetes.
    Thorvaldson L, Johansson SE, Höglund P, Sandler S.
    J Immunol Methods; 2005 Dec 20; 307(1-2):73-81. PubMed ID: 16263129
    [Abstract] [Full Text] [Related]

  • 18. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
    Zhang S, Yan X, Zhou PC, Huang C, Yang L, Li X, Lin J, Zhou ZG.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 26; 88(8):568-72. PubMed ID: 18649776
    [Abstract] [Full Text] [Related]

  • 19. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice.
    Campbell IL, Kay TW, Oxbrow L, Harrison LC.
    J Clin Invest; 1991 Feb 26; 87(2):739-42. PubMed ID: 1899431
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.